352 related articles for article (PubMed ID: 27249748)
1. The Role of Imaging in the Treatment of Patients With Multiple Myeloma in 2016.
Terpos E; Dimopoulos MA; Moulopoulos LA
Am Soc Clin Oncol Educ Book; 2016; 35():e407-17. PubMed ID: 27249748
[TBL] [Abstract][Full Text] [Related]
2. Comparative study of fluorodeoxyglucose positron emission tomography and magnetic resonance imaging for the detection of spinal bone marrow infiltration in untreated patients with multiple myeloma.
Hur J; Yoon CS; Ryu YH; Yun MJ; Suh JS
Acta Radiol; 2008 May; 49(4):427-35. PubMed ID: 18415787
[TBL] [Abstract][Full Text] [Related]
3. Multiple Myeloma Guidelines and Their Recent Updates: Implications for Imaging.
Mosebach J; Thierjung H; Schlemmer HP; Delorme S
Rofo; 2019 Nov; 191(11):998-1009. PubMed ID: 31137045
[TBL] [Abstract][Full Text] [Related]
4. Prospective Evaluation of Magnetic Resonance Imaging and [
Moreau P; Attal M; Caillot D; Macro M; Karlin L; Garderet L; Facon T; Benboubker L; Escoffre-Barbe M; Stoppa AM; Laribi K; Hulin C; Perrot A; Marit G; Eveillard JR; Caillon F; Bodet-Milin C; Pegourie B; Dorvaux V; Chaleteix C; Anderson K; Richardson P; Munshi NC; Avet-Loiseau H; Gaultier A; Nguyen JM; Dupas B; Frampas E; Kraeber-Bodere F
J Clin Oncol; 2017 Sep; 35(25):2911-2918. PubMed ID: 28686535
[TBL] [Abstract][Full Text] [Related]
5. Serum levels of carboxy-terminal telopeptide of type-I collagen are elevated in patients with multiple myeloma showing skeletal manifestations in magnetic resonance imaging but lacking lytic bone lesions in conventional radiography.
Jakob C; Zavrski I; Heider U; Bollow M; Schulz CO; Fleissner C; Eucker J; Michael R; Hamm B; Possinger K; Sezer O
Clin Cancer Res; 2003 Aug; 9(8):3047-51. PubMed ID: 12912955
[TBL] [Abstract][Full Text] [Related]
6. FDG-PET in the evaluation of myeloma in 2012.
Bodet-Milin C; Eugène T; Bailly C; Lacombe M; Frampas E; Dupas B; Moreau P; Kraeber-Bodéré F
Diagn Interv Imaging; 2013 Feb; 94(2):184-9. PubMed ID: 23287424
[TBL] [Abstract][Full Text] [Related]
7. 18F-FDG PET/CT in myeloma with presumed solitary plasmocytoma of bone.
Nanni C; Rubello D; Zamagni E; Castellucci P; Ambrosini V; Montini G; Cavo M; Lodi F; Pettinato C; Grassetto G; Franchi R; Gross MD; Fanti S
In Vivo; 2008; 22(4):513-7. PubMed ID: 18712181
[TBL] [Abstract][Full Text] [Related]
8. Role of magnetic resonance imaging in the management of patients with multiple myeloma: a consensus statement.
Dimopoulos MA; Hillengass J; Usmani S; Zamagni E; Lentzsch S; Davies FE; Raje N; Sezer O; Zweegman S; Shah J; Badros A; Shimizu K; Moreau P; Chim CS; Lahuerta JJ; Hou J; Jurczyszyn A; Goldschmidt H; Sonneveld P; Palumbo A; Ludwig H; Cavo M; Barlogie B; Anderson K; Roodman GD; Rajkumar SV; Durie BG; Terpos E
J Clin Oncol; 2015 Feb; 33(6):657-64. PubMed ID: 25605835
[TBL] [Abstract][Full Text] [Related]
9. Role of
Cavo M; Terpos E; Nanni C; Moreau P; Lentzsch S; Zweegman S; Hillengass J; Engelhardt M; Usmani SZ; Vesole DH; San-Miguel J; Kumar SK; Richardson PG; Mikhael JR; da Costa FL; Dimopoulos MA; Zingaretti C; Abildgaard N; Goldschmidt H; Orlowski RZ; Chng WJ; Einsele H; Lonial S; Barlogie B; Anderson KC; Rajkumar SV; Durie BGM; Zamagni E
Lancet Oncol; 2017 Apr; 18(4):e206-e217. PubMed ID: 28368259
[TBL] [Abstract][Full Text] [Related]
10. Myeloma bone and extra-medullary disease: Role of PET/CT and other whole-body imaging techniques.
Rubini G; Niccoli-Asabella A; Ferrari C; Racanelli V; Maggialetti N; Dammacco F
Crit Rev Oncol Hematol; 2016 May; 101():169-83. PubMed ID: 26997302
[TBL] [Abstract][Full Text] [Related]
11. Role of 18F-FDG PET/CT in the assessment of bone involvement in newly diagnosed multiple myeloma: preliminary results.
Nanni C; Zamagni E; Farsad M; Castellucci P; Tosi P; Cangini D; Salizzoni E; Canini R; Cavo M; Fanti S
Eur J Nucl Med Mol Imaging; 2006 May; 33(5):525-31. PubMed ID: 16453155
[TBL] [Abstract][Full Text] [Related]
12. Whole-body imaging of bone marrow.
Schmidt GP; Reiser MF; Baur-Melnyk A
Semin Musculoskelet Radiol; 2009 Jun; 13(2):120-33. PubMed ID: 19455475
[TBL] [Abstract][Full Text] [Related]
13. Multiple myeloma: 18F-FDG-PET/CT and diagnostic imaging.
Mihailovic J; Goldsmith SJ
Semin Nucl Med; 2015 Jan; 45(1):16-31. PubMed ID: 25475376
[TBL] [Abstract][Full Text] [Related]
14. Imaging of Multiple Myeloma.
Kosmala A; Bley T; Petritsch B
Rofo; 2019 Sep; 191(9):805-816. PubMed ID: 31185511
[TBL] [Abstract][Full Text] [Related]
15. Modern radiographic imaging in multiple myeloma, what is the minimum requirement?
Mena E; Turkbey EB; Lindenberg L
Semin Oncol; 2022 Feb; 49(1):86-93. PubMed ID: 35190200
[TBL] [Abstract][Full Text] [Related]
16. The role of imaging techniques in the management of multiple myeloma.
Zamagni E; Cavo M
Br J Haematol; 2012 Dec; 159(5):499-513. PubMed ID: 22881361
[TBL] [Abstract][Full Text] [Related]
17. Whole-body MRI, dynamic contrast-enhanced MRI, and diffusion-weighted imaging for the staging of multiple myeloma.
Dutoit JC; Verstraete KL
Skeletal Radiol; 2017 Jun; 46(6):733-750. PubMed ID: 28289855
[TBL] [Abstract][Full Text] [Related]
18. Imaging in multiple myeloma.
Delorme S; Baur-Melnyk A
Recent Results Cancer Res; 2011; 183():133-47. PubMed ID: 21509684
[TBL] [Abstract][Full Text] [Related]
19. Value of whole body MRI and dynamic contrast enhanced MRI in the diagnosis, follow-up and evaluation of disease activity and extent in multiple myeloma.
Dutoit JC; Vanderkerken MA; Verstraete KL
Eur J Radiol; 2013 Sep; 82(9):1444-52. PubMed ID: 23726124
[TBL] [Abstract][Full Text] [Related]
20. The Critical Role of Imaging in the Management of Multiple Myeloma.
Raza S; Leng S; Lentzsch S
Curr Hematol Malig Rep; 2017 Jun; 12(3):168-175. PubMed ID: 28317080
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
